4Q

Synlogic Provides Corporate Update and Outlook for 2023

Retrieved on: 
Thursday, January 5, 2023

CAMBRIDGE, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to synthetic biology, today summarized accomplishments for 2022 and outlined anticipated key milestones for 2023.

Key Points: 
  • CAMBRIDGE, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to synthetic biology, today summarized accomplishments for 2022 and outlined anticipated key milestones for 2023.
  • The Company is expected to begin its Phase 3 trial in PKU in the first half of this year.
  • In addition, SYNB1353 was granted Rare Pediatric Disease Designation (RPDD) by the U.S. Food and Drug Administration (FDA) for the potential treatment of HCU.
  • Synlogic will also report its 4Q and full year 2022 financial results in March 2023.

Eos Energy Enterprises Reports First Quarter 2021 Financial Results

Retrieved on: 
Wednesday, May 12, 2021

These costs were partially offset by a $1.6 million reversal of a reserve for losses on firm purchase commitments that we had recorded in 4Q \xe2\x80\x9920.

Key Points: 
  • These costs were partially offset by a $1.6 million reversal of a reserve for losses on firm purchase commitments that we had recorded in 4Q \xe2\x80\x9920.
  • Additional priorities include:\nEos will host a conference call to discuss its first quarter 2021 financial results on May 12, 2021, at 8:30 a.m.
  • ET on May 12, 2021, through May 19, 2021, by dialing 1-844-512-2921, or for international callers 1-412-317-6671.
  • The replay passcode will be 13718829.\nEos Energy Enterprises, Inc. is accelerating the shift to clean energy with positively ingenious solutions that transform how the world stores power.

Global Corporate Exposure to Rule 10b-5 Securities Class Actions Amounts to $37.8 billion in 1Q 2021

Retrieved on: 
Friday, April 9, 2021

U.S. SCA Rule 10b-5 Exposure of U.S. issuers amounts to $33.6 billion in 1Q'21, a material decline of 65.7% relative to 4Q'20.

Key Points: 
  • U.S. SCA Rule 10b-5 Exposure of U.S. issuers amounts to $33.6 billion in 1Q'21, a material decline of 65.7% relative to 4Q'20.
  • According to the SAR Securities Class Action Rule 10b-5 Exposure Report 1Q 2021 , the U.S. SCA Rule 10b-5 Exposure Rate of U.S. issuers declined to 0.08% in 1Q'21 from 0.25% in 4Q'20.
  • The Large Cap SCA Rule 10b-5 Exposure amounts to $22.8 billion, a material decline of 75.6% relative to 4Q'20.
  • The Mid Cap SCA Rule 10b-5 Exposure amounts to $2.4 billion, an increase of $228 million, or 10.6% relative to 4Q'20.

Ethernet Controller and Adapter Revenue Declined 13 Percent in Midst of Inventory Correction in 4Q 2020, According to Dell'Oro Group

Retrieved on: 
Thursday, March 11, 2021

REDWOOD CITY, Calif., March 11, 2021 /PRNewswire/ --In a newly published report by Dell'Oro Group, the trusted source for information about the telecommunications and networking industries, Ethernet controller and adapter revenue declined 13 percent quarter-over-quarter as a result of inventory correction in 4Q 2020.

Key Points: 
  • REDWOOD CITY, Calif., March 11, 2021 /PRNewswire/ --In a newly published report by Dell'Oro Group, the trusted source for information about the telecommunications and networking industries, Ethernet controller and adapter revenue declined 13 percent quarter-over-quarter as a result of inventory correction in 4Q 2020.
  • Meanwhile, leading vendors, Broadcom, Intel, and Nvidia, have reported initial shipments of adapters based on next-generation 56 Gbps PAM-4 SerDes.
  • "In 4Q 2020, the market decline was attributed to several cases of inventory correction," said Baron Fung, Research Director at Dell'Oro Group.
  • Additional highlights from the 4Q 2020 Ethernet Controller and Adapter report include:
    Total Ethernet controller and adapter port shipments declined 20 percent quarter-over-quarter.

TCS Group Holding PLC reports record net profit in FY'20; announces dividend plans for FY'21 and guidance for FY'21

Retrieved on: 
Thursday, March 11, 2021

The interest yield on the Group's securities portfolio decreased to 5.0% (4Q'19: 6.4%), in connection with declining rouble interest rates.

Key Points: 
  • The interest yield on the Group's securities portfolio decreased to 5.0% (4Q'19: 6.4%), in connection with declining rouble interest rates.
  • Our risk-adjusted net interest margin rose from 13.1% in 3Q'20 to 13.2% on 4Q'20 (4Q'19: 14.1%).
  • In 4Q'20 non-credit revenue represented 43% of the Group's revenue and 27% of the Group's profit before tax.
  • The Group reported robust quarterly net profit of RUB 12.3 bn in 4Q'20 (4Q'19: RUB 11.0 bn), supported by continued customer acquisition and monetisation.

The Campus Switch Market Witnessed a Setback in the Fourth Quarter of 2020, According to Dell'Oro Group

Retrieved on: 
Tuesday, March 9, 2021

"Government stimulus around the world, which propelled market recovery in 3Q 2020, continued in the fourth quarter of 2020," said Sameh Boujelbene, Senior Director at Dell'Oro Group.

Key Points: 
  • "Government stimulus around the world, which propelled market recovery in 3Q 2020, continued in the fourth quarter of 2020," said Sameh Boujelbene, Senior Director at Dell'Oro Group.
  • "However, 4Q 2020 did not benefit from pent-up demand from large enterprises as much as the prior quarter did.
  • Additional highlights from the 4Q 2020 Ethernet Switch Campus Report:
    Despite the market decline, verticals that performed well during the quarter are government and public sector, lower education, financial sector, and manufacturing.
  • Major vendors with revenue share gain for the quarter as well as for the year are H3C, HPE, and Huawei.

FibroGen Reports Fourth Quarter and Full Year 2020 Financial Results

Retrieved on: 
Monday, March 1, 2021

SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today reported financial results for the fourth quarter and full year 2020 and provided an update on the companys recent developments.

Key Points: 
  • SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today reported financial results for the fourth quarter and full year 2020 and provided an update on the companys recent developments.
  • Enrollment was completed in the WHITNEY US Phase 2 roxadustat clinical trial in chemotherapy-induced anemia (CIA) in 4Q 2020.
  • Total revenue for the fourth quarter of 2020 was $65.0 million, as compared to $8.0 million for the fourth quarter of 2019.
  • To participate in the conference call by telephone, please dial 1 (877) 658-9081 (U.S. and Canada) or 1 (602) 563-8732 (international), reference the FibroGen fourth quarter and full year 2020 financial results conference call, and use confirmation number 3055327.

VTB Group announces IFRS results for the full year and the fourth quarter of 2020

Retrieved on: 
Thursday, February 25, 2021

Net interest margin was 3.8% for both FY 2020 and 4Q 2020, up from 3.4% and 3.5% for FY 2019 and 4Q 2019, respectively.

Key Points: 
  • Net interest margin was 3.8% for both FY 2020 and 4Q 2020, up from 3.4% and 3.5% for FY 2019 and 4Q 2019, respectively.
  • The Group continues to take measures to reduce costs and improve operational efficiency in line with its strategy and long-term development priorities.
  • VTB Capital Investments' assets under management increased in FY 2020 and 4Q 2020 by 74% and 16%, respectively, to RUB 3.4 trillion.
  • VTB transferred processing for all pre-approved loans and digital credit cards through VTB Online to a new retail credit conveyor (RCC 2.0).

Fla.'s Housing Market Wraps Up 2020 with Strong Gains Despite COVID-19

Retrieved on: 
Thursday, February 11, 2021

"It's a testament to Florida's resilient housing market and ongoing buyer demand that home sales at the end of the year topped 2019's totals.

Key Points: 
  • "It's a testament to Florida's resilient housing market and ongoing buyer demand that home sales at the end of the year topped 2019's totals.
  • "Sales of Florida homes in the fourth quarter were very strong compared to a year ago," said Florida Realtors Chief Economist Dr. Brad O'Connor.
  • The statewide median sales price for existing single-family homes for 4Q 2020 was $306,000, up 14.6% from 4Q 2019.
  • Looking at Florida's year-to-year comparison for sales of condo-townhouses, a total of 119,336 units sold statewide in 2020, up 2.5% over 2019.

UTMD Reports Audited Year 2020 and Fourth Quarter Financial Performance

Retrieved on: 
Thursday, January 28, 2021

Operating Income declined more than gross profit in both 4Q 2020 and year 2020.

Key Points: 
  • Operating Income declined more than gross profit in both 4Q 2020 and year 2020.
  • In 4Q 2020, the lower operating income was due to a lower GPM, as 4Q 2020 sales were higher and 4Q 2020 operating expenses were $150 lower than in 4Q 2019.
  • Total consolidated 4Q 2020 UTMD sales were $179 (1.5%) higher than in 4Q 2019.
  • Filshie device sales direct to U.S. domestic end-user facilities were $129 (7%) lower in 4Q 2020 compared to 4Q 2019.